Three down, two to go when it comes to major regulatory hurdles that Medtronic and Covidien need to clear for their proposed $43 billion merger. The U.S. Federal Trade Commission, the European Union and Canada’s Competition Bureau ...
Sapheon has announced the Health Canada approval for its VenaSeal sapheon closure system, designed to treat venous reflux disease (varicose veins). VenaSeal features a specially formulated medical adhesive that closes the saphenous vein. ...
US-based Sapheon has submitted the first module of pre-market approval (PMA) application to the US Food and Drug Administration (FDA) for its VenaSeal sapheon closure system, designed to treat venous reflux (varicose veins) disease. This ...
Tags: PMA Application, Medicine
Sapheon has reported one year follow-up results from a 38-patient clinical study of its VenaSeal Sapheon closure system, designed to treat saphenous vein disease. VenaSeal system, which comprises a proprietary vein sealant and custom ...
Sapheon, a developer of technologies for the treatment of vascular diseases, has completed the first closing in its $18.5m Series B Preferred equity offering. The company said the proceeds from the Series B offering will be used to ...